35 Results

People

  1. Ni
    Ni
  2. Zelenetz
    Zelenetz
  3. Matasar
    Matasar
  4. Horwitz
    Horwitz
  5. Younes
    Younes
  6. Batlevi
    Batlevi
  7. Hamlin
    Hamlin
  8. Kumar
    Kumar
  9. Moskowitz
    Moskowitz
  10. Moskowitz
    Moskowitz

Groups

  1. Biostatistics Service (35)
  2. Center for Hematologic Malignancies (35)
  3. Department of Medicine (35)
  4. Epidemiology and Biostatistics (35)
  5. Hematologic Malignancies, Division of (35)
  6. Lymphoma (35)
  7. Survivorship Research (23)
  8. Executive Committee, Center for Hematologic Malignancies (21)
  9. Population Sciences Research Program (19)
  10. Sloan Kettering Institute Postdocs (18)
  1. "Center for Hematologic Malignancies"
  2. "Lymphoma"
  3. "Ai Ni"
Formats
  1. Meeting Abstract (21)
  2. Journal Article (14)
Groups
  1. Biostatistics Service (35)
  2. Center for Hematologic Malignancies (35)
  3. Department of Medicine (35)
  4. Epidemiology and Biostatistics (35)
  5. Hematologic Malignancies, Division of (35)
  6. Lymphoma (35)

More Groups

People
  1. Ai Ni (35)
  2. Andrew Zelenetz (26)
  3. Matthew Matasar (23)
  4. Anas Younes (19)
  5. Steven Horwitz (19)
  6. Connie Batlevi (17)

More People

Years
  1. 2022 (1)
  2. 2021 (2)
  3. 2020 (5)
  4. 2019 (10)
  5. 2018 (3)
  6. 2017 (11)

More Years

Publications
  1. Blood (11)
  2. Hematological Oncology (8)
  3. Journal of Clinical Oncology (4)
  4. Leukemia and Lymphoma (4)
  5. Blood Cancer Journal (2)
  6. The Lancet Haematology (2)

More Publications

Publishers
  1. American Society of Hematology (11)
  2. Wiley Blackwell (8)
  3. American Society of Clinical Oncology (4)
  4. Taylor & Francis Group (4)
  5. Elsevier Science, Inc. (3)
  6. Elsevier Inc. (2)

More Publishers

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma
    Journal Article

    Fischer, T.; Ni, A.; Bantilan, K. S.; Soumerai, J. D.; Alperovich, A.; Batlevi, C.; Younes, A.; Zelenetz, A. D.
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax in chronic lymphocytic leukemia: Early MRD kinetics define a high-risk patient cohort with delayed bone marrow undetectable MRD and earlier post-treatment MRD recurrence
    Meeting Abstract

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E. P.; Barnes, J. A.; Hamilton, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial
    Journal Article

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma
    Journal Article

    Soumerai, J. D.; Ni, A.; Alperovich, A.; Batlevi, C.; Bantilan, K. S.; Fischer, T.; Copeland, A. R.; Smith, K.; Ying, Z.; Younes, A.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Follicular lymphoma in the modern era: Survival, treatment outcomes, and identification of high-risk subgroups
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Caron, P. C.; Falchi, L.; Hamilton, A.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants
    Journal Article

    Cordeiro, P. G.; Ghione, P.; Ni, A.; Hu, Q.; Ganesan, N.; Galasso, N.; Dogan, A.; Horwitz, S. M.
    Journal of Plastic Reconstructive and Aesthetic Surgery (2020)

    Fulltext@MSK | Save
  • Incidence of infectious complications with the combination of bendamustine and an anti-CD20 monoclonal antibody
    Journal Article

    Sarlo, K. M.; Dixon, B. N.; Ni, A.; Straus, D. J.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Gerecitano, J. F.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials
    Journal Article

    Soumerai, J. D.; Ni, A.; Xing, G.; Huang, J.; Furman, R. R.; Jones, J.; Sharman, J. P.; Hallek, M.; Adewoye, A. H.; Dubowy, R.; more...
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Real-world assessment of practice efficiency with the introduction of subcutaneous rituximab
    Meeting Abstract

    Qiu, A.; Shapouri, S.; Drill, E. N.; Schade, J.; Ravelo, A.; Ni, A.; To, T. M.; Dawson, K. L.; Matasar, M. J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save